Novel Insights and Therapeutics in Multiple Sclerosis [v1; ref status: indexed, http://f1000r.es/59z]
The last twelve years have witnessed the development of new therapies for relapsing-remitting multiple sclerosis that demonstrate increased efficacy relative to previous therapies. Many of these new drugs target the inflammatory phase of disease by manipulating different aspects of the immune system...
Main Authors: | Catriona A. Wagner, Joan M. Goverman |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2015-08-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/4-517/v1 |
Similar Items
-
Defining the functional states of Th17 cells [v1; ref status: indexed, http://f1000r.es/51y]
by: Youjin Lee, et al.
Published: (2015-05-01) -
Innate B cells: oxymoron or validated concept? [v1; ref status: indexed, http://f1000r.es/T4CAVP]
by: Carl F Ware, et al.
Published: (2012-08-01) -
Global identification of genes and pathways regulated by Akt during activation of T helper cells [v1; ref status: indexed, http://f1000r.es/107]
by: Jing Cheng, et al.
Published: (2013-04-01) -
The second touch hypothesis: T cell activation, homing and polarization [v2; ref status: indexed, http://f1000r.es/3zq]
by: Klaus Ley
Published: (2014-08-01) -
Global identification of genes and pathways regulated by Akt during activation of T helper cells [v2; ref status: indexed, http://f1000r.es/14h]
by: Jing Cheng, et al.
Published: (2013-05-01)